Drug and Therapeutics Bulletin 1997;35:95; doi:10.1136/dtb.1997.351295
Copyright © 1997 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Intrapleural streptokinase for empyema?

Relevant BNF section: 2.10.2

Pus collection within the pleural cavity (empyema) is a potentially fatal complication of pneumonia. Typically, treatment includes drainage of the infected fluid. Several small uncontrolled studies have suggested that drainage via a catheter can be improved by the intrapleural instillation of low-dose streptokinase. The first randomised controlled trial of this use of streptokinase has been published recently.1 We discuss the implications of this study's findings.




This article has been cited by other articles:


Home page
ChestHome page
C. W. H. Davies, Z. C. Traill, F. V. Gleeson, and R. J. O. Davies
Intrapleural Streptokinase in the Management of Malignant Multiloculated Pleural Effusions
Chest, March 1, 1999; 115(3): 729 - 733.
[Abstract] [Full Text] [PDF]



About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1997 BMJ Publishing Group Ltd.